SUPRIYA LIFESCIENCE LTD

Overview

SUPRIYA LIFESCIENCE LTD is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering ALBUTEROL SULFATE USP; ALLOPURINOL USP; BISOPROLOL FUMARATE USP; BROMPHENIRAMINE MALEATE; BUPRIOPION HYDROCHLORIDE USP; CETIRIZINE HYDROCHLORIDE USP.

API / Drug Master Files

SUPRIYA LIFESCIENCE LTD holds 21 active (21 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MIDAZOLAM USPActive2025-12-11
• SEVOFLURANE USPActive2025-11-16
• TRAMADOL HYDROCHLORIDE USP-(PROCESS II)Active2025-09-26
• ALLOPURINOL USPActive2024-03-05
• TRAMADOL HYDROCHLORIDE USPActive2024-02-29
• CETIRIZINE HYDROCHLORIDE USPActive2024-02-06
• HYDROXOCOBALAMIN USPActive2022-06-04
• ESKETAMINE HYDROCHLORIDEActive2021-11-08
• DEXCHLORPHENIRAMINE MALEATE USPActive2021-04-17
• METHYLCOBALAMIN USPActive2021-03-31
• BISOPROLOL FUMARATE USPActive2021-02-16
• DIPHENHYDRAMINE HYDROCHLORIDE USPActive2020-09-03
• DEXTROMETHORPHAN HYDROBROMIDE USPActive2019-03-25
• BUPRIOPION HYDROCHLORIDE USPActive2019-01-25
• ALBUTEROL SULFATE USPActive2016-06-27

Showing 15 of 21 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SUPRIYA LIFESCIENCE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.